Our Pricing

Wegovy Discount Code UK: Online Prescription & Lowest Prices

Published on: June 03, 2026

Searching for a wegovy discount code uk online that actually works? At Cured Pharmacy, we offer transparent upfront pricing on genuine UK-licensed Wegovy (semaglutide) injections from £79.00, with free clinical consultation by UK prescribers and discreet next-day delivery. No hidden fees, no inflated market rates—just the lowest prices guaranteed across the UK.

How Wegovy Works for Weight Loss

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with weight-related comorbidities [1]. Semaglutide mimics the natural GLP-1 hormone, which regulates appetite by acting on brain receptors that control hunger and satiety.

In the landmark STEP 1 trial, participants using Wegovy achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. The once-weekly subcutaneous injection works by slowing gastric emptying, reducing food cravings, and helping patients feel fuller for longer periods between meals.

Clinical data shows that semaglutide's effects extend beyond appetite suppression—patients in STEP trials also experienced improvements in cardiovascular risk markers, including reductions in waist circumference, blood pressure, and HbA1c levels [2]. These outcomes make Wegovy a comprehensive tool for weight management when combined with dietary modifications and increased physical activity.

Wegovy Discount Code UK: Understanding Pricing

At Cured Pharmacy, Wegovy starts from £79.00 per pen, significantly lower than typical market rates. Our transparent pricing model means you see the exact cost before completing your free online consultation—no surprise fees at checkout.

Many UK patients search for discount codes, but the most effective savings come from choosing a pharmacy with consistently low base prices rather than relying on temporary promotional codes that expire. Our pricing structure reflects bulk purchasing agreements and streamlined online operations, allowing us to pass genuine savings directly to patients.

Dosing typically follows a gradual escalation schedule over 16-20 weeks, starting at 0.25 mg weekly and increasing to the maintenance dose of 2.4 mg weekly, subject to prescriber approval [3]. Your UK-registered clinician will determine the appropriate dose progression based on your individual response and tolerability during the free assessment.

Transparent Pricing vs Hidden Costs

Unlike some online services that advertise low headline prices but add consultation fees, delivery charges, or mandatory subscription plans, Cured Pharmacy displays all costs upfront. The price you see is the price you pay—our free clinical assessment is genuinely free, and we never require long-term commitments or auto-renewal subscriptions without your explicit consent.

Wegovy vs Alternative Weight Loss Treatments

Several prescription weight loss medications are licensed in the UK, each with distinct mechanisms and clinical profiles. Wegovy's once-weekly injection schedule offers convenience compared to daily alternatives, and head-to-head trials demonstrate superior weight loss outcomes versus older GLP-1 treatments [2].

Saxenda (liraglutide) requires daily injections and achieved an average weight reduction of 8% in the SCALE trial—approximately half the average reduction seen with Wegovy in comparable patient populations [4]. Orlistat, a lipase inhibitor, works through a completely different mechanism by blocking dietary fat absorption but typically produces more modest weight loss of 3-5% and may cause gastrointestinal side effects.

Your UK prescriber will assess your medical history, current medications, and weight loss goals to recommend the most appropriate treatment. Factors including injection frequency preference, budget considerations, and previous treatment responses all influence the clinical decision.

Semaglutide vs Tirzepatide

Tirzepatide (available as Mounjaro) represents a newer dual GIP/GLP-1 receptor agonist that demonstrated greater average weight loss in the SURPASS trials—up to 22.5% body weight reduction at the highest dose [5]. However, Wegovy remains the more established option with extensive long-term safety data and broader clinical experience among UK prescribers. Both require weekly injections and clinical assessment before prescribing.

Starting Wegovy: The Online Prescription Process

All Wegovy prescriptions at Cured Pharmacy begin with a free online clinical assessment completed by UK-registered prescribers. The consultation takes under 3 minutes and covers your medical history, current medications, weight loss goals, and any contraindications to GLP-1 therapy.

Our clinical team, overseen by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), reviews every assessment to ensure Wegovy is clinically appropriate and safe for your individual circumstances. If approved, your prescription is dispensed from our UK-registered pharmacy (GPhC 9012511) and dispatched in 100% discreet packaging with next-day delivery options.

The assessment includes questions about previous weight loss attempts, cardiovascular history, thyroid conditions, and family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2—both absolute contraindications to GLP-1 therapy [3]. Honest, complete answers ensure your safety and treatment efficacy.

What to Expect After Approval

Once your prescription is approved, you'll receive detailed injection technique instructions, dose escalation schedules, and guidance on managing potential side effects such as nausea or constipation. Most patients experience gastrointestinal symptoms during the initial weeks, which typically improve as the body adjusts to treatment. Our clinical team remains available for questions throughout your treatment journey.

Wegovy Side Effects and Safety Considerations

The most commonly reported side effects in STEP trials were gastrointestinal: nausea (44% of participants), diarrhoea (30%), vomiting (24%), and constipation (24%) [1]. These effects were generally mild to moderate in severity and decreased over time as patients adapted to treatment.

Serious but rare risks include pancreatitis, gallbladder disease, and hypoglycaemia in patients taking concurrent diabetes medications. Wegovy carries a boxed warning in some jurisdictions regarding thyroid C-cell tumours observed in rodent studies, though no causal relationship has been established in humans [3]. Your prescriber will assess your individual risk profile during consultation.

Patients should report persistent severe abdominal pain, visual changes, rapid heartbeat, or signs of allergic reaction immediately. Wegovy is contraindicated in pregnancy, and women of childbearing potential should use effective contraception during treatment and for 2 months after discontinuation. Regular follow-up with your healthcare provider ensures ongoing safety monitoring and dose optimisation.

Maximising Results: Diet and Lifestyle with Wegovy

Clinical trials demonstrating Wegovy's efficacy included intensive lifestyle interventions—participants received dietary counselling and were encouraged to reduce caloric intake by 500 kcal daily while increasing physical activity to at least 150 minutes weekly [1]. Medication alone, without behavioural modifications, produces suboptimal outcomes.

A balanced diet rich in lean proteins, vegetables, and whole grains supports both weight loss and minimises gastrointestinal side effects. Smaller, more frequent meals may improve tolerability during dose escalation phases. Adequate hydration (at least 2 litres daily) helps prevent constipation, a common early side effect.

Resistance training alongside cardiovascular exercise helps preserve lean muscle mass during weight loss, improving metabolic outcomes and long-term weight maintenance. NICE guidelines emphasise that pharmacotherapy should complement, not replace, sustainable lifestyle changes that patients can maintain after treatment completion. Your UK prescriber may recommend referral to registered dietitians or exercise physiologists for additional support.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
3. Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen - Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
4. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
5. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.